Decheng Capital Global Life Sciences Fund IV, L.P.
Follow-ons only
Follow-ons only: no first sale reported; age from Form D filed Dec 2020 (approximate)
- Vintage
- Unknown
- Fund size
- $650M (Form D)
- Stages
- Seed, Series A, Growth
- Sectors
- Biotech, Medical devices, Healthtech, Life sciences and research tools
- Regions
- Global
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$6.5M to $10.83M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Fengying Yu, Manager of the General Partner of the Issuer
- Xiangmin Cui, Manager of the General Partner of the Issuers
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideDecheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence.
Decheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence.
http://www.decheng.com/
06 · Sources
Last verified: Oct 28, 2026